Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
Jyh‐Ming Liou(National Taiwan University), Ming‐Shiang Wu(National Taiwan University), Chun‐Chao Chang(Taipei Medical University Hospital), Jaw‐Town Lin(National Health Research Institutes), Wen-Hao Hu(National Taiwan University Hospital), Yao‐Chun Hsu(China Medical University), Ming‐Jong Bair(Mackay Medical College), Ji-Yuh Lee(National Taiwan University Hospital), Chia‐Tung Shun(National Taiwan University), Jiing‐Chyuan Luo(Taipei Veterans General Hospital), Cheng-Hao Tseng(I-Shou University), Wen‐Feng Hsu(National Taiwan University Hospital), Chieh‐Chang Chen(National Taiwan University Hospital), Mei‐Jyh Chen(National Taiwan University), Yen-Nien Chen(National Taiwan University Hospital), Jeng–Yih Wu(Kaohsiung Medical University Chung-Ho Memorial Hospital), Chien-Chuan Chen(National Taiwan University Hospital), Chi-Yang Chang(I-Shou University), Po-Yueh Chen(Chia-Yi Christian Hospital), Bor‐Shyang Sheu(National Cheng Kung University Hospital), Chi-Yi Chen(Chia-Yi Christian Hospital), Yu-Jen Fang(National Taiwan University Hospital), Emad El‐Omar(Sutherland Hospital), Tsung‐Hua Yang(National Taiwan University), Yi‐Chia Lee(National Taiwan University)
Cited by 202
Related Papers
Management of <i>Helicobacter pylori</i> infection—the Maastricht V/Florence Consensus Report
|Gut|2016|2.9k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Management of <i>Helicobacter pylori</i> infection—the Maastricht IV/ Florence Consensus Report
|Gut|2012|2.3k
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis
|Gastroenterology|2016|1k
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830